Literature DB >> 4592701

Double-blind and open prospective studies on lithium prophylaxis in affective disorders.

A Coppen, M Peet, J Bailey, R Noguera, B H Burns, M S Swani, R Maggs, R Gardner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4592701

Source DB:  PubMed          Journal:  Psychiatr Neurol Neurochir        ISSN： 0033-2666


× No keyword cloud information.
  8 in total

1.  Age as a factor affecting lithium therapy.

Authors:  D S Hewick; P Newbury; S Hopwood; G Naylor; J Moody
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 2.  Lithium versus antidepressants in the long-term treatment of unipolar affective disorder.

Authors:  A Cipriani; K Smith; S Burgess; S Carney; G Goodwin; J Geddes
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

3.  Assessment of drugs in schizophrenia. Discussion on basic trial design.

Authors:  A Coppen
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

4.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

Review 5.  Lithium in the prophylaxis of unipolar depression: a review.

Authors:  A Coppen; M T Abou-Saleh
Journal:  J R Soc Med       Date:  1983-04       Impact factor: 18.000

Review 6.  Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression.

Authors:  Mohammed T Abou-Saleh; Bruno Müller-Oerlinghausen; Alec J Coppen
Journal:  Int J Bipolar Disord       Date:  2017-05-08

7.  A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder.

Authors:  T P Hui; A Kandola; L Shen; G Lewis; D P J Osborn; J R Geddes; J F Hayes
Journal:  Acta Psychiatr Scand       Date:  2019-06-30       Impact factor: 6.392

8.  Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report.

Authors:  Mirko Manchia; Mazda Adli; Nirmala Akula; Raffaella Ardau; Jean-Michel Aubry; Lena Backlund; Claudio Em Banzato; Bernhard T Baune; Frank Bellivier; Susanne Bengesser; Joanna M Biernacka; Clara Brichant-Petitjean; Elise Bui; Cynthia V Calkin; Andrew Tai Ann Cheng; Caterina Chillotti; Sven Cichon; Scott Clark; Piotr M Czerski; Clarissa Dantas; Maria Del Zompo; J Raymond Depaulo; Sevilla D Detera-Wadleigh; Bruno Etain; Peter Falkai; Louise Frisén; Mark A Frye; Jan Fullerton; Sébastien Gard; Julie Garnham; Fernando S Goes; Paul Grof; Oliver Gruber; Ryota Hashimoto; Joanna Hauser; Urs Heilbronner; Rebecca Hoban; Liping Hou; Stéphane Jamain; Jean-Pierre Kahn; Layla Kassem; Tadafumi Kato; John R Kelsoe; Sarah Kittel-Schneider; Sebastian Kliwicki; Po-Hsiu Kuo; Ichiro Kusumi; Gonzalo Laje; Catharina Lavebratt; Marion Leboyer; Susan G Leckband; Carlos A López Jaramillo; Mario Maj; Alain Malafosse; Lina Martinsson; Takuya Masui; Philip B Mitchell; Frank Mondimore; Palmiero Monteleone; Audrey Nallet; Maria Neuner; Tomás Novák; Claire O'Donovan; Urban Osby; Norio Ozaki; Roy H Perlis; Andrea Pfennig; James B Potash; Daniela Reich-Erkelenz; Andreas Reif; Eva Reininghaus; Sara Richardson; Guy A Rouleau; Janusz K Rybakowski; Martin Schalling; Peter R Schofield; Oliver K Schubert; Barbara Schweizer; Florian Seemüller; Maria Grigoroiu-Serbanescu; Giovanni Severino; Lisa R Seymour; Claire Slaney; Jordan W Smoller; Alessio Squassina; Thomas Stamm; Jo Steele; Pavla Stopkova; Sarah K Tighe; Alfonso Tortorella; Gustavo Turecki; Naomi R Wray; Adam Wright; Peter P Zandi; David Zilles; Michael Bauer; Marcella Rietschel; Francis J McMahon; Thomas G Schulze; Martin Alda
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.